Immunovant, Inc. IMVT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s retained earnings?
- Immunovant, Inc. (IMVT) reported retained earnings of -$1.75B in Q1 2026.
- How has Immunovant, Inc.'s retained earnings changed year-over-year?
- Immunovant, Inc.'s retained earnings decreased by 40.8% year-over-year, from -$1.24B to -$1.75B.
- What is the long-term trend for Immunovant, Inc.'s retained earnings?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s retained earnings has grown at a 54.4% compound annual growth rate (CAGR), from -$198.66M to -$1.75B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.